On October 5, 2023, Aion Therapeutic Inc. closed the transaction. The company has issued 21,500,000 units at a price of CAD 0.01 per unit, for gross proceeds of CAD 215,000 in its second tranche closing. Including the first tranche of the unit offering, the company has issued a total of 64,250,000 units for total gross proceeds of CAD 642,500 in the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 6.05M | |
+42.64% | 6.38B | |
-15.52% | 4.59B | |
+8.35% | 3.39B | |
-11.10% | 3.2B | |
-4.12% | 2.52B | |
+46.46% | 2B | |
-7.97% | 1.7B | |
-1.07% | 1.65B | |
-11.56% | 1.58B |
- Stock Market
- Equities
- AION Stock
- News Aion Therapeutic Inc.
- Aion Therapeutic Inc. announced that it has received CAD 0.6425 million in funding